Pro-inflammatory NF-κB and early growth response gene 1 regulate epithelial barrier disruption by food additive carrageenan in human intestinal epithelial cells

Toxicology Letters

Volumn 211, Issue 3, 2012, Pages 289-295

  Choi, Hye Jin ^a   Kim, Juil ^a   Park, Seong Hwan ^a   Do, Kee Hun ^a   Yang, Hyun ^a   Moon, Yuseok ^a,b  

^a Pusan National University School of Medicine   (South Korea)

^b Pusan National University   (South Korea)

Author keywords

CGN; EGR 1; Intestinal epithelial barrier; NF B

Indexed keywords

CARRAGEENAN; EARLY GROWTH RESPONSE FACTOR 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; PROTEIN ZO1;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; INTESTINAL EPITHELIAL BARRIER; INTESTINE EPITHELIUM CELL; MONOLAYER CULTURE; PERMEABILITY BARRIER; PRIORITY JOURNAL; RISK ASSESSMENT; TIGHT JUNCTION;

BLOTTING, WESTERN; CACO-2 CELLS; CARCINOGENS; CARRAGEENAN; CELL LINE; EARLY GROWTH RESPONSE PROTEIN 1; ELECTRIC IMPEDANCE; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITHELIAL CELLS; FOOD ADDITIVES; GENE EXPRESSION; HT29 CELLS; HUMANS; INTERLEUKIN-8; INTESTINAL ABSORPTION; INTESTINAL MUCOSA; MICROSCOPY, CONFOCAL; NF-KAPPA B; PLASMIDS; REAL-TIME POLYMERASE CHAIN REACTION; TRANSFECTION;

ANIMALIA;

EID: 84860684351     PISSN: 03784274     EISSN: 18793169     Source Type: Journal    
DOI: 10.1016/j.toxlet.2012.04.012     Document Type: Article

References (52)

1. Ahmed M.M., Sells S.F., Venkatasubbarao K., Fruitwala S.M., Muthukkumar S., Harp C., Mohiuddin M., Rangnekar V.M. Ionizing radiation-inducible apoptosis in the absence of p53 linked to transcription factor EGR-1. Journal of Biological Chemistry 1997, 272:33056-33061.
2. Alcantara Warren C., Destura R.V., Sevilleja J.E., Barroso L.F., Carvalho H., Barrett L.J., O'Brien A.D., Guerrant R.L. Detection of epithelial-cell injury, and quantification of infection, in the HCT-8 organoid model of cryptosporidiosis. Journal of Infectious Diseases 2008, 198:143-149.
3. Benard C., Cultrone A., Michel C., Rosales C., Segain J.P., Lahaye M., Galmiche J.P., Cherbut C., Blottiere H.M. Degraded carrageenan causing colitis in rats induces TNF secretion and ICAM-1 upregulation in monocytes through NF-kappaB activation. PLoS One 2010, 5:e8666.
4. Berndt U., Bartsch S., Philipsen L., Danese S., Wiedenmann B., Dignass A.U., Hammerle M., Sturm A. Proteomic analysis of the inflamed intestinal mucosa reveals distinctive immune response profiles in Crohn's disease and ulcerative colitis. Journal of Immunology 2007, 179:295-304.
5. Bhattacharyya S., Dudeja P.K., Tobacman J.K. Carrageenan-induced NFkappaB activation depends on distinct pathways mediated by reactive oxygen species and Hsp27 or by Bcl10. Biochimica et Biophysica Acta 2008, 1780:973-982.
6. Borthakur A., Bhattacharyya S., Dudeja P.K., Tobacman J.K. Carrageenan induces interleukin-8 production through distinct Bcl10 pathway in normal human colonic epithelial cells. American Journal of Physiology. Gastrointestinal and Liver Physiology 2007, 292:G829-G838.
7. Braddock M. The transcription factor Egr-1: a potential drug in wound healing and tissue repair. Annals of Medicine 2001, 33:313-318.
8. Chapman N.R., Perkins N.D. Inhibition of the RelA(p65) NF-kappaB subunit by Egr-1. Journal of Biological Chemistry 2000, 275:4719-4725.
9. Chen L.W., Egan L., Li Z.W., Greten F.R., Kagnoff M.F., Karin M. The two faces of IKK and NF-kappaB inhibition: prevention of systemic inflammation but increased local injury following intestinal ischemia-reperfusion. Nature Medicine 2003, 9:575-581.
10. Choi H.J., Seo C.H., Park S.H., Yang H., Do K.H., Kim J., Kim H.K., Chung D.H., Ahn J.H., Moon Y. Involvement of epidermal growth factor receptor-linked signaling responses in Pseudomonas fluorescens-infected alveolar epithelial cells. Infection and Immunity 2011, 79:1998-2005.
11. Cogswell P.C., Mayo M.W., Baldwin A.S. Involvement of Egr-1/RelA synergy in distinguishing T cell activation from tumor necrosis factor-alpha-induced NF-kappa B1 transcription. Journal of Experimental Medicine 1997, 185:491-497.
12. Dieckgraefe B.K., Weems D.M. Epithelial injury induces egr-1 and fos expression by a pathway involving protein kinase C and ERK. American Journal of Physiology 1999, 276:G322-G330.
13. Edelblum K.L., Turner J.R. The tight junction in inflammatory disease: communication breakdown. Current Opinion in Pharmacology 2009, 9:715-720.
14. Egan L.J., de Lecea A., Lehrman E.D., Myhre G.M., Eckmann L., Kagnoff M.F. Nuclear factor-kappaB activation promotes restitution of wounded intestinal epithelial monolayers. American Journal of Physiology. Cell Physiology 2003, 285:C1028-C1035.
15. Egan L.J., Eckmann L., Greten F.R., Chae S., Li Z.W., Myhre G.M., Robine S., Karin M., Kagnoff M.F. IkappaB-kinasebeta-dependent NF-kappaB activation provides radioprotection to the intestinal epithelium. Proceedings of the National Academy of Sciences of the United States of America 2004, 101:2452-2457.
16. Ishioka T., Kuwabara N., Oohashi Y., Wakabayashi K. Induction of colorectal tumors in rats by sulfated polysaccharides. Critical Reviews in Toxicology 1987, 17:215-244.
17. Karrasch T., Jobin C. NF-kappaB and the intestine: friend or foe?. Inflammatory Bowel Diseases 2008, 14:114-124.
18. Karrasch T., Kim J.S., Jang B.I., Jobin C. The flavonoid luteolin worsens chemical-induced colitis in NF-kappaB (EGFP) transgenic mice through blockade of NF-kappaB-dependent protective molecules. PLoS One 2007, 2:e596.
19. Kataoka T., Teraoka J., Sakoda A., Nishiyama Y., Yamato K., Monden M., Ishimori Y., Nomura T., Taguchi T., Yamaoka K. Protective effects of radon inhalation on carrageenan-induced inflammatory paw edema in mice. Inflammation 2011.
20. Khachigian L.M., Collins T. Inducible expression of Egr-1-dependent genes. A paradigm of transcriptional activation in vascular endothelium. Circulation Research 1997, 81:457-461.
21. Khomenko T., Szabo S., Deng X., Jadus M.R., Ishikawa H., Osapay K., Sandor Z., Chen L. Suppression of early growth response factor-1 with egr-1 antisense oligodeoxynucleotide aggravates experimental duodenal ulcers. American Journal of Physiology. Gastrointestinal and Liver Physiology 2006, 290:G1211-G1218.
22. Kim H.S., Berstad A. Experimental colitis in animal models. Scandinavian Journal of Gastroenterology 1992, 27:529-537.
23. Ling K.Y., Bhalla D., Hollander D. Mechanisms of carrageenan injury of IEC18 small intestinal epithelial cell monolayers. Gastroenterology 1988, 95:1487-1495.
24. Liu Y., Lu J.B., Ye Z.R. Permeability of injured blood brain barrier for exogenous bFGF and protection mechanism of bFGF in rat brain ischemia. Neuropathology 2006, 26:257-266.
25. Milbrandt J. A nerve growth factor-induced gene encodes a possible transcriptional regulatory factor. Science 1987, 238:797-799.
26. Moon Y., Lee M., Yang H. Involvement of early growth response gene 1 in the modulation of microsomal prostaglandin E synthase 1 by epigallocatechin gallate in A549 human pulmonary epithelial cells. Biochemical Pharmacology 2007, 73:125-135.
27. Moon Y., Yang H., Kim Y.B. Up-regulation of early growth response gene 1 (EGR-1) via ERK1/2 signals attenuates sulindac sulfide-mediated cytotoxicity in the human intestinal epithelial cells. Toxicology and Applied Pharmacology 2007, 223:155-163.
28. Mumy K.L., Bien J.D., Pazos M.A., Gronert K., Hurley B.P., McCormick B.A. Distinct isoforms of phospholipase A2 mediate the ability of Salmonella enterica serotype typhimurium and Shigella flexneri to induce the transepithelial migration of neutrophils. Infection and Immunity 2008, 76:3614-3627.
29. Murphy L.O., MacKeigan J.P., Blenis J. A network of immediate early gene products propagates subtle differences in mitogen-activated protein kinase signal amplitude and duration. Molecular and Cellular Biology 2004, 24:144-153.
30. Oohashi Y., Ishioka T., Wakabayashi K., Kuwabara N. A study on carcinogenesis induced by degraded carrageenan arising from squamous metaplasia of the rat colorectum. Cancer Letters 1981, 14:267-272.
31. Pasparakis M. Regulation of tissue homeostasis by NF-kappaB signalling: implications for inflammatory diseases. Nature Reviews Immunology 2009, 9:778-788.
32. Pricolo V.E., Madhere S.M., Finkelstein S.D., Reichner J.S. Effects of lambda-carrageenan induced experimental enterocolitis on splenocyte function and nitric oxide production. Journal of Surgical Research 1996, 66:6-11.
33. Schreiber S., Nikolaus S., Hampe J. Activation of nuclear factor kappa B inflammatory bowel disease. Gut 1998, 42:477-484.
34. Schulzke J.D., Ploeger S., Amasheh M., Fromm A., Zeissig S., Troeger H., Richter J., Bojarski C., Schumann M., Fromm M. Epithelial tight junctions in intestinal inflammation. Annals of the New York Academy of Sciences 2009, 1165:294-300.
35. Schwarz B.T., Wang F., Shen L., Clayburgh D.R., Su L., Wang Y., Fu Y.X., Turner J.R. LIGHT signals directly to intestinal epithelia to cause barrier dysfunction via cytoskeletal and endocytic mechanisms. Gastroenterology 2007, 132:2383-2394.
36. Sharratt M., Grasso P., Carpanini F., Gangolli S.D. Carrageenan ulceration as a model for human ulcerative colitis. Lancet 1971, 1:192-193.
37. Shen F., Walker E.J., Jiang L., Degos V., Li J., Sun B., Heriyanto F., Young W.L., Su H. Coexpression of angiopoietin-1 with VEGF increases the structural integrity of the blood-brain barrier and reduces atrophy volume. Journal of Cerebral Blood Flow and Metabolism 2011.
38. Sifuentes L.Y., Di Giovanni G.D. Aged HCT-8 cell monolayers support Cryptosporidium parvum infection. Applied and Environment Microbiology 2007, 73:7548-7551.
39. Spehlmann M.E., Eckmann L. Nuclear factor-kappa B in intestinal protection and destruction. Current Opinion in Gastroenterology 2009, 25:92-99.
40. Strauch E.D., Yamaguchi J., Bass B.L., Wang J.Y. Bile salts regulate intestinal epithelial cell migration by nuclear factor-kappa B-induced expression of transforming growth factor-beta. Journal of the American College of Surgeons 2003, 197:974-984.
41. Suenaert P., Bulteel V., Lemmens L., Noman M., Geypens B., Van Assche G., Geboes K., Ceuppens J.L., Rutgeerts P. Anti-tumor necrosis factor treatment restores the gut barrier in Crohn's disease. American Journal of Gastroenterology 2002, 97:2000-2004.
42. Szabo S., Deng X., Khomenko T., Yoshida M., Jadus M.R., Sandor Z., Gombos Z., Matsumoto H. Gene expression and gene therapy in experimental duodenal ulceration. Journal of Physiology, Paris 2001, 95:325-335.
43. Szabo S., Khomenko T., Gombos Z., Deng X.M., Jadus M.R., Yoshida M. Review article: transcription factors and growth factors in ulcer healing. Alimentary Pharmacology and Therapeutics 2000, 14(Suppl. 1):33-43.
44. Thebault S., Deniel N., Marion R., Charlionet R., Tron F., Cosquer D., Leprince J., Vaudry H., Ducrotte P., Dechelotte P. Proteomic analysis of glutamine-treated human intestinal epithelial HCT-8 cells under basal and inflammatory conditions. Proteomics 2006, 6:3926-3937.
45. Thiele K., Bierhaus A., Autschbach F., Hofmann M., Stremmel W., Thiele H., Ziegler R., Nawroth P.P. Cell specific effects of glucocorticoid treatment on the NF-kappaBp65/IkappaBalpha system in patients with Crohn's disease. Gut 1999, 45:693-704.
46. Tobacman J.K. Review of harmful gastrointestinal effects of carrageenan in animal experiments. Environmental Health Perspectives 2001, 109:983-994.
47. Visekruna A., Joeris T., Seidel D., Kroesen A., Loddenkemper C., Zeitz M., Kaufmann S.H., Schmidt-Ullrich R., Steinhoff U. Proteasome-mediated degradation of IkappaBalpha and processing of p105 in Crohn disease and ulcerative colitis. Journal of Clinical Investigation 2006, 116:3195-3203.
48. Watt J., Marcus R. Carrageenan-induced ulceration of the large intestine in the guinea pig. Gut 1971, 12:164-171.
49. Wells C.L., van de Westerlo E.M., Jechorek R.P., Haines H.M., Erlandsen S.L. Cytochalasin-induced actin disruption of polarized enterocytes can augment internalization of bacteria. Infection and Immunity 1998, 66:2410-2419.
50. Wong W.M., Playford R.J., Wright N.A. Peptide gene expression in gastrointestinal mucosal ulceration: ordered sequence or redundancy?. Gut 2000, 46:286-292.
51. Yan S.F., Zou Y.S., Gao Y., Zhai C., Mackman N., Lee S.L., Milbrandt J., Pinsky D., Kisiel W., Stern D. Tissue factor transcription driven by Egr-1 is a critical mechanism of murine pulmonary fibrin deposition in hypoxia. Proceedings of the National Academy of Sciences of the United States of America 1998, 95:8298-8303.
52. Yao H., Duan M., Buch S. Cocaine-mediated induction of platelet-derived growth factor: implication for increased vascular permeability. Blood 2011, 117:2538-2547.